Barinthus Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BRNS and buy or sell other stocks, ETFs, and their options commission-free!About BRNS
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs.
CEOWilliam Enright
CEOWilliam Enright
Employees14
Employees14
HeadquartersGermantown, Maryland
HeadquartersGermantown, Maryland
Founded2021
Founded2021
Employees14
Employees14
BRNS Key Statistics
Market cap30.23M
Market cap30.23M
Price-Earnings ratio-0.72
Price-Earnings ratio-0.72
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.40
52 Week high$1.40
52 Week low$0.512
52 Week low$0.512
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.